Eloxx Pharmaceuticals, Inc., Zikani Therapeutics, Inc. - M&A Call Transcript
Ladies and gentlemen, thank you for standing by, and welcome to the Eloxx Pharmaceuticals conference call and webcast to discuss the acquisition of Zikani Therapeutics. (Operator Instructions) Please be advised that today's conference is being recorded.
I would now like to hand the conference to your speaker today, John Woolford. John, you may begin.
Thank you, Victor. Good morning, and thank you to everyone who has joined today's call to discuss Eloxx Pharmaceuticals' acquisition of Zikani Therapeutics. A press release announcing the acquisition was issued this morning and is currently available at both www.eloxxpharma.com and www.zikani.com. An audio archive of this conference call will be available on the Eloxx Pharmaceuticals' website in the Investor Relations section later today. Also, please note that there are slides to accompany today's event. These slides are available
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |